Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two s…
Medical - Diagnostics & Research
US, Burlington [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -24.31 | 49.79 | 65.78 | |
| Graham Fair Price | 18.55 | 75.98 | 64.09 | |
| PEG | -43.88 | -0.08 | 0.15 | |
| Price/Book | -6.71 | 2.29 | 2.45 | |
| Price/Cash Flow | 137.68 | -111.22 | 46.79 | |
| Prices/Earnings | -30.90 | 19.95 | -28.87 | |
| Price/Sales | -9.96 | 5.73 | 6.36 | |
| Price/FCF | 137.68 | -111.22 | 46.79 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Somewhat Weak
Fundamentals
Profitability
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 4.88 | 0.26 | 0.25 | |
| Operating Margin | 36.92 | 0.10 | 0.08 | |
| ROA | 38.05 | 0.01 | < 0.005 | |
| ROE | -0.02 | 0.03 | 35.00 | |
| ROIC | 0.02 | 0.02 | -3.84 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | < 0.005 | -0.06 | -95.95 | |
| Dividends QOQ | -0.02 | 0.03 | 5.52 | |
| EBIT QOQ | -0.09 | 0.43 | 376.00 | |
| EPS QOQ | -1.93 | 2.38 | 23.14 | |
| FCF QOQ | 1.42 | -1.40 | -1.46 | |
| Revenue QOQ | < 0.005 | 0.05 | 514.51 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Positive
Fundamentals
Leverage & Liquidity
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 18.81 | 18.27 | -2.84 | |
| Days Sales Outstanding (DSO) | 62.27 | 62.45 | 0.28 | |
| Inventory Turnover | 4.79 | 4.93 | 2.92 | |
| Debt/Capitalization | 0.40 | 0.40 | -0.18 | |
| Quick Ratio | 0.82 | 0.58 | -28.48 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Book Value | 92.76 | 94.64 | 2.04 | |
| Cash | 6.32 | 1.18 | -81.33 | |
| Capex | -1.97 | -1.59 | 19.21 | |
| Free Cash Flow | 4.86 | -1.95 | -59.95 | |
| Revenue | 35.73 | 37.77 | 5.72 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Weak
Fundamentals
Financial Health
06 - Financial Health ·
Bad